Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 27;43(8):114570.
doi: 10.1016/j.celrep.2024.114570. Epub 2024 Aug 1.

Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages

Affiliations
Free article

Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages

Luke A Bourner et al. Cell Rep. .
Free article

Abstract

A wide variety of electrophilic derivatives of itaconate, the Kreb's cycle-derived metabolite, are immunomodulatory, yet these derivatives have overlapping and sometimes contradictory activities. Therefore, we generated a genetic system to interrogate the immunomodulatory functions of endogenously produced itaconate in human macrophages. Endogenous itaconate is driven by multiple innate signals restraining inflammatory cytokine production. Endogenous itaconate directly targets cysteine 13 in IRAK4 (disrupting IRAK4 autophosphorylation and activation), drives the degradation of nuclear factor κB, and modulates global ubiquitination patterns. As a result, cells unable to make itaconate overproduce inflammatory cytokines such as tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), and IL-1β in response to these innate activators. In contrast, the production of interferon (IFN)β, downstream of LPS, requires the production of itaconate. These data demonstrate that itaconate is a critical arbiter of inflammatory cytokine production downstream of multiple innate signaling pathways, laying the groundwork for the development of itaconate mimetics for the treatment of autoimmunity.

Keywords: ACOD1; CP: Immunology; IRAK4; IRG1; MYC; immunometabolism; itaconate; macrophage.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests L.A.B., L.A.C., H.L., J.X., K.R., B.T., F.J.O., D.C.G., L.Z., Y.C.W., M.J.C., C.-W.Y., J.A.G., and F.C.D. are employees and shareholders of Eli Lilly and Company. L.A.J.O., M.S., and J.D.B. are employees or shareholders of Sitryx.

References

Publication types

MeSH terms